{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:29:01Z","timestamp":1787887741285,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oulu University Hospital VTR","award":["K74809"],"award-info":[{"award-number":["K74809"]}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helsinki University Hospital Research","award":["TYH2016131"],"award-info":[{"award-number":["TYH2016131"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.antiviral.2017.09.019","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T11:30:16Z","timestamp":1506771016000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency"],"prefix":"10.1016","volume":"147","author":[{"given":"Ludmila","family":"Perelygina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-1614","authenticated-orcid":false,"given":"Timo","family":"Hautala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9733-3650","authenticated-orcid":false,"given":"Mikko","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-1606","authenticated-orcid":false,"given":"Adebola","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4018-1646","authenticated-orcid":false,"given":"Kathleen E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Icenogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.09.019_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcv.2015.06.084","article-title":"Genomic characterization of a persistent rubella virus from a case of Fuch' uveitis syndrome in a 73 year old man","volume":"69","author":"Abernathy","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib2","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.09.019_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.21.2.259","article-title":"Alpha interferon administration to infants with congenital rubella","volume":"21","author":"Arvin","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.09.019_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virol.2014.05.015","article-title":"Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores","volume":"462\u2013463","author":"Ashiru","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.09.019_bib5","doi-asserted-by":"crossref","first-page":"O656","DOI":"10.1111\/1469-0691.12573","article-title":"Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency","volume":"20","author":"Bodemer","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2017.09.019_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5414\/CPP38387","article-title":"Nitazoxanide: pharmacokinetics and metabolism in man","volume":"38","author":"Broekhuysen","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2017.09.019_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0883073812469443","article-title":"Childhood rubella encephalitis: diagnosis, management, and outcome","volume":"29","author":"Chaari","year":"2014","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jviromet.2007.08.021","article-title":"An indirect immunocolorimetric assay to detect rubella virus infected cells","volume":"146","author":"Chen","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2017.09.019_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1185\/030079905X50534","article-title":"Use of nitazoxanide as a new therapeutic option for persistent diarrhea: a pediatric perspective","volume":"21","author":"Cohen","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.antiviral.2017.09.019_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13073-016-0344-6","article-title":"Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens","volume":"8","author":"Doan","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.antiviral.2017.09.019_bib11","first-page":"49","article-title":"Histopathology of gestational rubella","volume":"118","author":"Driscoll","year":"1969","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.antiviral.2017.09.019_bib12","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1053\/j.gastro.2009.07.056","article-title":"The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation","volume":"137","author":"Elazar","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2017.09.019_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: a new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.019_bib14","first-page":"287","article-title":"Rubella arthritis in adults. Isolation of virus, cytology and other aspects of the synovial reaction","volume":"1","author":"Fraser","year":"1983","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/aid.2014.0015","article-title":"Nitazoxanide inhibits HIV viral replication in monocyte-derived macrophages","volume":"31","author":"Gekonge","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.antiviral.2017.09.019_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s15010-007-6322-6","article-title":"Encephalitis in a child during atypical course of rubella","volume":"37","author":"Guler","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2017.09.019_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.019_bib18","article-title":"Nitazoxanide may modify the course of progressive multifocal leukoencephalopathy","author":"Hautala","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1083\/jcb.121.2.269","article-title":"The rubella virus E2 and E1 spike glycoproteins are targeted to the Golgi complex","volume":"121","author":"Hobman","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.intimp.2012.03.002","article-title":"Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice","volume":"13","author":"Hong","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2017.09.019_bib22","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3748\/wjg.15.1805","article-title":"Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides","volume":"15","author":"Keeffe","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2007.08.005","article-title":"Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication","volume":"77","author":"Korba","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.019_bib24","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1128\/JVI.01213-13","article-title":"Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation","volume":"87","author":"La Frazia","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1998.9098","article-title":"Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription","volume":"244","author":"Lai","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.09.019_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/viro.2001.0862","article-title":"Rubella virus RNA replication is cis-preferential and synthesis of negative- and positive-strand RNAs is regulated by the processing of nonstructural protein","volume":"282","author":"Liang","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.09.019_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cid\/ciw675","article-title":"Cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in children with primary immunodeficiencies","volume":"64","author":"Neven","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.019_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133267","article-title":"Differences in establishment of persistence of vaccine and wild type rubella viruses in fetal endothelial cells","volume":"10","author":"Perelygina","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.09.019_bib29","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jaci.2016.06.030","article-title":"Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies","volume":"138","author":"Perelygina","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073014","article-title":"Persistent infection of human fetal endothelial cells with rubella virus","volume":"8","author":"Perelygina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.09.019_bib31","series-title":"Infectious Diseases of the Fetus and Newborn Infant","first-page":"861","article-title":"Rubella","author":"Plotkin","year":"2011"},{"key":"10.1016\/j.antiviral.2017.09.019_bib32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/17425250902988487","article-title":"Thiazolides: a new class of antiviral drugs","volume":"5","author":"Rossignol","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.antiviral.2017.09.019_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.019_bib34","doi-asserted-by":"crossref","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level","volume":"284","author":"Rossignol","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.09.019_bib35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.antiviral.2017.09.019_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-11-10","article-title":"Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model","volume":"11","author":"Shi","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2017.09.019_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026908","article-title":"A simple protocol for using a ldh-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time","volume":"6","author":"Smith","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.09.019_bib38","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1021\/jm201264t","article-title":"Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication","volume":"54","author":"Stachulski","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.019_bib39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/152.3.606","article-title":"Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia","volume":"152","author":"Tingle","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.019_bib40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-3476(66)80204-4","article-title":"Fetal rubella pathology","volume":"68","author":"Tondury","year":"1966","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2017.09.019_bib41","doi-asserted-by":"crossref","first-page":"27148","DOI":"10.1038\/srep27148","article-title":"Thiazolides elicit anti-viral innate immunity and reduce hiv","volume":"6","author":"Trabattoni","year":"2016","journal-title":"Replication. Sci. Rep."},{"key":"10.1016\/j.antiviral.2017.09.019_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2016.10.003","article-title":"Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission","volume":"135","author":"Wang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.019_bib43","first-page":"359","article-title":"Immunochemical features of a case of progressive rubella panencephalitis","volume":"48","author":"Wolinsky","year":"1982","journal-title":"Clin. Exp. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T01:51:46Z","timestamp":1535334706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217306460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":43,"alternative-id":["S0166354217306460"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}